Substance Use Disorders: ICD-10-CM vs DSM-5

Why the two systems don’t match—and what providers should document to stay compliant

Yan Mei Jiang, CPC, CPMA, CRC

3/17/20262 min read

photo of white staircase
photo of white staircase

Substance Use Disorders sit at the intersection of clinical care, behavioral health, and risk adjustment. One of the biggest sources of confusion is that DSM‑5 and ICD‑10‑CM do not use the same terminology, even though both describe the same clinical condition. That mismatch leads to documentation gaps, miscoding, and audit risk—especially when “dependence” is used incorrectly.

How DSM‑5 Defines SUD

DSM‑5 uses a single, unified diagnosis: Substance Use Disorder, categorized by severity:

  • Mild — 2–3 criteria

  • Moderate — 4–5 criteria

  • Severe — 6+ criteria

DSM‑5 no longer uses the terms abuse or dependence. Instead, it evaluates a spectrum of problematic use based on 11 criteria (impaired control, social impairment, risky use, and pharmacologic indicators).

  1. Taking the substance in larger amounts or for longer than intended.

  2. Wanting to cut down or stop using the substance but being unable to.

  3. Spending a lot of time obtaining, using, or recovering from the substance.

  4. Craving or having strong urges to use the substance.

  5. Recurrent use resulting in failure to meet major obligations at work, school, or home.

  6. Continued use despite persistent or recurrent social or interpersonal problems caused or worsened by the substance.

  7. Giving up or reducing important social, occupational, or recreational activities because of use.

  8. Repeated use in situations where it is physically hazardous.

  9. Continued use despite knowing it is causing or worsening physical or psychological problems.

  10. Developing tolerance (needing more of the substance to achieve the same effect).

  11. Experiencing withdrawal symptoms or using the substance to avoid withdrawal.

How ICD‑10‑CM Defines SUD

ICD‑10‑CM still uses two separate constructs:

  • Abuse (e.g., F10.10 Alcohol abuse, uncomplicated)

  • Dependence (e.g., F11.20 Opioid dependence, uncomplicated)

Dependence codes risk‑adjust. Abuse codes do not.

ICD‑10‑CM also includes “use” codes (e.g., F12.90 Cannabis use, unspecified) when the provider documents use without meeting criteria for abuse or dependence.

Why This Matters

Because DSM‑5 is used clinically and ICD‑10‑CM is used for billing, providers often document DSM‑5 language (“mild SUD”) while coders must assign ICD‑10‑CM codes (“abuse” vs “dependence”). Without clear documentation, coders cannot ethically or compliantly infer severity or dependence.

Documentation Tips for Providers

These points help bridge DSM‑5 clinical language to ICD‑10‑CM coding requirements.

1. State the diagnosis clearly

Use explicit terms such as:

  • “Opioid use disorder—moderate”

  • “Alcohol use disorder—severe”

  • “Cocaine use disorder—in early remission”

Avoid vague statements like:

  • “Substance issues”

  • “Problematic drinking”

  • “History of drug use” (unless truly historical)

2. Document DSM‑5 severity

Severity helps coders determine whether ICD‑10‑CM maps to abuse or dependence.

  • Mild SUD → often maps to abuse

  • Moderate or severe SUD → often maps to dependence

Coders cannot assume this without provider documentation.

3. Include MEAT

To support coding and risk adjustment, document:

  • Monitoring (cravings, withdrawal symptoms, relapse risk)

  • Evaluation (screening tools, functional impact)

  • Assessment (severity, remission status, complications)

  • Treatment (MAT, counseling, referrals)

4. Specify remission status

ICD‑10‑CM requires:
  • Early remission

  • Sustained remission

  • Or active use

“Stable” is not enough.

5. Use “dependence” only when clinically accurate

Dependence in ICD‑10‑CM implies a moderate or severe disorder with physiologic or behavioral components.
Do not document “dependence” unless DSM‑5 criteria are met.

Quick Provider‑Friendly Documentation Examples

Compliant:

“Opioid use disorder, severe. Patient reports cravings and withdrawal symptoms. Continuing buprenorphine therapy. Follow‑up in 2 weeks."

Risk-Prone:

“Opioid dependence—stable.”
(No MEAT, unclear criteria, no severity, no assessment.)